Literature DB >> 15589795

In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.

Pharath Lim1, Pheaktra Chim, Rithy Sem, Sina Nemh, Yi Poravuth, Chiv Lim, Soun Seila, Reiko Tsuyuoka, Mey Bouth Denis, Doung Socheat, Thierry Fandeur.   

Abstract

We used a classical isotopic microtest to assess the in vitro sensitivity of 352 Plasmodium falciparum isolates collected in Cambodia in 2001 and 2002 to chloroquine, mefloquine, quinine and artesunate. Our results confirm conclusions drawn from earlier studies conducted by the Cambodian national malaria centre. Chloroquine-resistant phenotypes were highly prevalent in Cambodia. Similarly, a high proportion of isolates displayed elevated IC50 to mefloquine. In contrast, only 0.67 and 1.7% of isolates presented decreased susceptibility to quinine and artesunate, respectively. Distributions of mean IC50 according to drug and geographic origin indicated that the parasites circulating to the west of Cambodia largely account for the global situation of drug resistances in Cambodia. Isolates with decreased susceptibility to chloroquine and mefloquine were common along the border with Thailand. In contrast, most of the isolates from eastern Cambodia were susceptible to these compounds. Isolates collected at the western and eastern borders did not respond differently to artesunate. No major differences in responses to antimalarial drugs were observed between 2001 and 2002, suggesting that the situation of drug resistance is now stabilized and under control in Cambodia. However, the decreased susceptibility of isolates collected in the western provinces of Cambodia to mefloquine and the correlation between susceptibility to artesunate and susceptibility to mefloquine and quinine justify the need for an improved international surveillance program for malaria drug resistance in the Mekong sub region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15589795     DOI: 10.1016/j.actatropica.2004.09.002

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

Review 1.  Drug resistance and genetic mapping in Plasmodium falciparum.

Authors:  Karen Hayton; Xin-Zhuan Su
Journal:  Curr Genet       Date:  2008-09-18       Impact factor: 3.886

2.  High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.

Authors:  Charles J Woodrow; Sabina Dahlström; Richard Cooksey; Jennifer A Flegg; Hervé Le Nagard; France Mentré; Claribel Murillo; Didier Ménard; François Nosten; Kanlaya Sriprawat; Lise Musset; Neils B Quashie; Pharath Lim; Rick M Fairhurst; Sam L Nsobya; Veronique Sinou; Harald Noedl; Bruno Pradines; Jacob D Johnson; Philippe J Guerin; Carol H Sibley; Jacques Le Bras
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

3.  Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.

Authors:  Nimol Khim; Christiane Bouchier; Marie-Thérèse Ekala; Sandra Incardona; Pharath Lim; Eric Legrand; Ronan Jambou; Socheat Doung; Odile Mercereau Puijalon; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.

Authors:  Mariama Issaka; Adamou Salissou; Ibrahim Arzika; Julia Guillebaud; Abani Maazou; Sabine Specht; Halima Zamanka; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

5.  Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites.

Authors:  Paul Hunt; Axel Martinelli; Katarzyna Modrzynska; Sofia Borges; Alison Creasey; Louise Rodrigues; Dario Beraldi; Laurence Loewe; Richard Fawcett; Sujai Kumar; Marian Thomson; Urmi Trivedi; Thomas D Otto; Arnab Pain; Mark Blaxter; Pedro Cravo
Journal:  BMC Genomics       Date:  2010-09-16       Impact factor: 3.969

6.  Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Authors:  Rithea Leang; Amy Barrette; Denis Mey Bouth; Didier Menard; Rashid Abdur; Socheat Duong; Pascal Ringwald
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

7.  Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.

Authors:  Nantana Suwandittakul; Wanna Chaijaroenkul; Pongchai Harnyuttanakorn; Mathirut Mungthin; Kesara Na Bangchang
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

8.  Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.

Authors:  Pharath Lim; Dalin Dek; Vorleak Try; Richard T Eastman; Sophy Chy; Sokunthea Sreng; Seila Suon; Sivanna Mao; Chantha Sopha; Baramey Sam; Elizabeth A Ashley; Olivo Miotto; Arjen M Dondorp; Nicholas J White; Xin-zhuan Su; Meng Chuor Char; Jennifer M Anderson; Chanaki Amaratunga; Didier Menard; Rick M Fairhurst
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

9.  Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia.

Authors:  Naman K Shah; Alisa P Alker; Rithy Sem; Agustina Ika Susanti; Sinuon Muth; Jason D Maguire; Socheat Duong; Frederic Ariey; Steven R Meshnick; Chansuda Wongsrichanalai
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

10.  Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.

Authors:  Pharath Lim; Alisa P Alker; Nimol Khim; Naman K Shah; Sandra Incardona; Socheat Doung; Poravuth Yi; Denis Mey Bouth; Christiane Bouchier; Odile Mercereau Puijalon; Steven R Meshnick; Chansuda Wongsrichanalai; Thierry Fandeur; Jacques Le Bras; Pascal Ringwald; Frédéric Ariey
Journal:  Malar J       Date:  2009-01-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.